- Report
- October 2024
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 89 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- February 2025
- 182 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- September 2024
- 154 Pages
Global
From €2136EUR$2,250USD£1,802GBP
- Report
- June 2024
- 120 Pages
North America
From €3673EUR$3,869USD£3,098GBP
- Report
- January 2020
- 508 Pages
Global
From €4651EUR$4,899USD£3,923GBP
- Report
- January 2020
- 300 Pages
Global
From €3133EUR$3,300USD£2,643GBP
- Report
- March 2023
- 139 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- December 2021
- 206 Pages
Global
From €2611EUR$2,750USD£2,202GBP
€5221EUR$5,500USD£4,404GBP
- Report
- October 2023
- 200 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- February 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- February 2024
- 110 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- May 2023
- 140 Pages
Global
From €4698EUR$4,949USD£3,963GBP
- Report
- November 2023
- 200 Pages
Global
€4742EUR$4,995USD£4,000GBP
- Report
- April 2022
- 80 Pages
Africa
From €1899EUR$2,000USD£1,602GBP
- Report
- April 2022
- 40 Pages
Brazil
From €1424EUR$1,500USD£1,201GBP
- Report
- April 2022
- 40 Pages
China
From €1424EUR$1,500USD£1,201GBP
- Report
- April 2022
- 40 Pages
France
From €1424EUR$1,500USD£1,201GBP
- Report
- April 2022
- 40 Pages
Germany
From €1424EUR$1,500USD£1,201GBP
- Report
- April 2022
- 40 Pages
India
From €1424EUR$1,500USD£1,201GBP
The Cancer Stem Cell (CSC) market is a subset of the larger stem cell market. CSCs are a type of stem cell that can cause cancer when they divide and grow uncontrollably. CSCs are believed to be responsible for the recurrence of cancer after treatment, and are the focus of much research into new treatments. CSCs are also being studied for their potential to be used in regenerative medicine.
CSCs are being studied for their potential to be used in personalized medicine, where treatments are tailored to the individual patient. CSCs are also being studied for their potential to be used in drug discovery and development, as they can be used to test the effectiveness of new drugs.
The CSC market is a rapidly growing field, with many companies investing in research and development. Companies such as Celgene, Novartis, and AstraZeneca are investing in CSC research, while companies such as Thermo Fisher Scientific and Bio-Rad are providing tools and services to support CSC research. Other companies such as StemCell Technologies and STEMCELL Technologies are providing products and services to support CSC research. Show Less Read more
